BioCentury
ARTICLE | Company News

Fyodor Biotechnologies, National Science Foundation (NSF) diagnostic news

September 24, 2012 7:00 AM UTC

Fyodor received a two-year, Phase II Small Business Innovation Research (SBIR) grant of $476,000 from the NSF. The funds will be used to develop and validate UMT Broad, a urine malaria test to diagnos...